【発明の名称】グルココルチコイド選択性薬剤

Japanese Patent JP2002521430

A

Compounds having Formula (I) are useful for modulating the glucocorticoid receptor in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I) and methods of treating immune, autoimmune, inflammatory, adrenal imbalance, cognitive and behavioral diseases in a mammal.

WO/2014/031177	TRANS-CLOMIPHENE FORMULATIONS AND USES THEREOF
JP2000502706	INDUSTRIAL APPLICABILITY: Retinoid-like biological activity ((3 "-thioxacyclohexa-1" -enyl))-buta-3'-en-1'-inyl) aryl and heteroarylcarboxylic acids and esters.
JP2957281	INDUSTRIAL APPLICABILITY A method of using a porous calcium carbonate-based substance as a support for a growth factor in the production of a bioabsorbable implant.

Coglan, Michael Jei
Lurie, J.A.R.
Shukkar Yants, Jefrey M
One, Alan Ecks

JP2000561992A

July 16, 2002

July 30, 1999

Click for automatic bibliography generation  

ABBOTT LABORATORIES

A61K31/00; A61K31/136; A61K31/137; A61K31/167; A61K31/222; A61K31/24; A61K31/27; A61K31/341; A61K31/40; A61K31/402; A61K31/4025; A61K31/4453; A61K31/45; A61K31/4545; A61K31/535; A61K31/5375; A61K31/5377; A61P5/38; A61P25/18; A61P25/20; A61P25/22; A61P29/00; C07D295/04; A61P37/00; C07C211/52; C07C215/16; C07C217/76; C07C217/84; C07C219/06; C07C219/10; C07C233/40; C07C233/43; C07C233/62; C07C233/80; C07C239/22; C07C271/28; C07C271/44; C07C275/26; C07C311/03; C07C323/29; C07D295/06; C07D307/36; C07D307/52; G05D23/13; (IPC1-7): A61K31/136; A61K31/167; A61K31/341; A61K31/402; A61K31/4453; A61K31/5375; A61P5/38; A61P25/18; A61P25/20; A61P25/22; A61P29/00; A61P37/00; C07C211/52; C07C215/16; C07C217/84; C07C233/43; C07C239/22; C07C271/44; C07C275/26; C07C311/03

JPH07316185A	1995-12-05
JPH09501172A	1997-02-04

US5112867A	1992-05-12
WO1997034589A1	1997-09-25
US3057881A	1962-10-09
WO1999002505A1	1999-01-21
WO1999032101A1	1999-07-01
WO1997037664A2	1997-10-16

Yoshio Kawaguchi (2 outside)

Previous Patent: JP2002521429

Next Patent: モクロベマイドの使用方法および組成物